In February 2026, the Department of Health and Human Services, Office of Inspector General (HHS-OIG) issued its highly anticipated Industry Compliance Program Guidance for Medicare Advantage (MA ICPG), the first such compliance guidance for the MA industry in over 25 years. The MA ICPG is the second industry segment-specific compliance guidance published in a series for providers, suppliers, and other participants in the health care industry. The first was a 2024 nursing facility ICPG.
The guidance comes as MA now covers more than half of all Medicare enrollees. The program’s capitated payment structure generally pays Medicare Advantage Organizations a fixed monthly amount per enrollee. This model creates financial incentives that run throughout the entire MA ecosystem, touching plans, providers, investors and vendors alike, but in a manner different from traditional fee-for-service. While the MA ICPG is voluntary, nonbinding guidance, it carries significant practical weight.
Read on to learn more about the guidance and why investors, owners and operators of MA-related businesses as well as providers contracting with MA plans should treat the MA ICPG as a signal of HHS-OIG’s current enforcement priorities and a benchmark against which their compliance programs will be measured.